Key facts
- This page summarizes Klaus Orlinger's Form 4 filing for HOOKIPA Pharma Inc. (HOOK).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Apr 2024, 16:15.
Klaus Orlinger - 15 Apr 2024 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- HOOK
- Reported as of
- 15 Apr 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Apr 2024, 16:15:29 UTC
- Prior SEC filing
- 18 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Reinhard Kandera, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Klaus Orlinger filed Form 4 for HOOKIPA Pharma Inc. (HOOK) on 17 Apr 2024.
Change
- Previous filing in this sequence was filed on 18 Apr 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HOOK
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +367,300
- Change %
- Price
- $0.000000
- Shares after
- 367,300
- Date
- 15 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 367,300
- Exercise price
- $0.7600
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
25% of this option shall vest on April 15, 2025, with the remainder vesting in 12 equal quarterly installments thereafter.